日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

复发评分指导治疗对N0 ER+乳腺癌患者十年临床疗效的影响

Stemmer, Salomon M; Steiner, Mariana; Rizel, Shulamith; Ben-Baruch, Noa; Uziely, Beatrice; Jakubowski, Debbie M; Baron, Julie; Shak, Steven; Soussan-Gutman, Lior; Bareket-Samish, Avital; Fried, Georgeta; Rosengarten, Ora; Itay, Amit; Nisenbaum, Bella; Katz, Daniela; Leviov, Michelle; Tokar, Margarita; Liebermann, Nicky; Geffen, David B

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?

BRCA基因携带者卵巢过早衰老:系统性早衰的原型?

Ben-Aharon Irit, Levi Mattan, Margel David, Yerushalmi Rinat, Rizel Shulamith, Perry Shlomit, Sharon Eran, Hasky Noa, Abir Ronit, Fisch Benny, Tobar Ana, Shalgi Ruth, Stemmer Salomon Marcello

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

根据复发评分结果接受治疗的ER+ HER2-淋巴结阳性乳腺癌患者的临床结局:来自大型前瞻性注册研究的证据

Stemmer, Salomon M; Steiner, Mariana; Rizel, Shulamith; Geffen, David B; Nisenbaum, Bella; Peretz, Tamar; Soussan-Gutman, Lior; Bareket-Samish, Avital; Isaacs, Kevin; Rosengarten, Ora; Fried, Georgeta; McCullough, Debbie; Svedman, Christer; Shak, Steven; Liebermann, Nicky; Ben-Baruch, Noa

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

基于复发评分结果治疗的淋巴结阴性乳腺癌患者的临床结局:来自大型前瞻性注册研究的证据

Stemmer, Salomon M; Steiner, Mariana; Rizel, Shulamith; Soussan-Gutman, Lior; Ben-Baruch, Noa; Bareket-Samish, Avital; Geffen, David B; Nisenbaum, Bella; Isaacs, Kevin; Fried, Georgeta; Rosengarten, Ora; Uziely, Beatrice; Svedman, Christer; McCullough, Debbie; Maddala, Tara; Klang, Shmuel H; Zidan, Jamal; Ryvo, Larisa; Kaufman, Bella; Evron, Ella; Karminsky, Natalya; Goldberg, Hadassah; Shak, Steven; Liebermann, Nicky

The association between smoking and breast cancer characteristics and outcome

吸烟与乳腺癌特征和预后之间的关联

Goldvaser, Hadar; Gal, Omer; Rizel, Shulamith; Hendler, Daniel; Neiman, Victoria; Shochat, Tzippy; Sulkes, Aaron; Brenner, Baruch; Yerushalmi, Rinat

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study

影响肿瘤科医护人员与逝世患者家属沟通模式的因素:一项横断面研究

Granot, Tal; Gordon, Noa; Perry, Shlomit; Rizel, Shulamith; Stemmer, Salomon M

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics

代谢紊乱治疗与乳腺癌特征之间的关联

Goldvaser, Hadar; Rizel, Shulamith; Hendler, Daniel; Neiman, Victoria; Shepshelovich, Daniel; Shochat, Tzippy; Sulkes, Aaron; Brenner, Baruch; Yerushalmi, Rinat

Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity

年轻乳腺癌患者化疗诱发卵巢功能衰竭的长期随访:血管毒性的作用

Ben-Aharon, Irit; Granot, Tal; Meizner, Israel; Hasky, Noa; Tobar, Ana; Rizel, Shulamith; Yerushalmi, Rinat; Ben-Haroush, Avi; Fisch, Benjamin; Stemmer, Salomon M

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

21基因复发评分检测对淋巴结阳性(最多3个阳性淋巴结)雌激素受体阳性乳腺癌患者临床决策的影响

Stemmer, Salomon M; Klang, Shmuel H; Ben-Baruch, Noa; Geffen, David B; Steiner, Mariana; Soussan-Gutman, Lior; Merling, Shahar; Svedman, Christer; Rizel, Shulamith; Lieberman, Nicky

Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity

化疗引起的卵巢功能衰竭作为急性血管毒性的原型

Ben-Aharon, Irit; Meizner, Israel; Granot, Tal; Uri, Shiri; Hasky, Noa; Rizel, Shulamith; Yerushalmi, Rinat; Sulkes, Aaron; Stemmer, Salomon M